Safety, Efficacy, Pharmacokinetic (Pk) And Biomarker Analyses Of Bcl2 Inhibitor Venetoclax (Ven) Plus Mdm2 Inhibitor Idasanutlin (Idasa) In Patients (Pts) With Relapsed Or Refractory (R/R) Aml: A Phase Ib, Non-Randomized, Open-Label StudyNaval G. Daver,Daniel A Pollyea,Jacqueline S. Garcia,Brian A. Jonas,Karen W.L. Yee,Pierre Fenaux,Sarit Assouline,Norbert Vey,Rebecca Olin,Gail J. Roboz,Agostino Tafuri,Giuseppe Visani,Whitney Kirschbrown,Cherie Green,Connie Ma,Monique Dail,Jue Wang,Marion G Ott,Mehrdad Mobasher,Patrick Phuong,Wan-Jen Hong,Marina Y. Konopleva,Michael AndreeffBLOOD（2018）引用 20|浏览23暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
